Diagnosis of Latent Tuberculosis in Patients with Systemic Lupus Erythematosus: T.SPOT.TB <i>versus</i> Tuberculin Skin Test

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">SLE patients</td><td align="center">Kappa value</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">All patients</td><td align="center">0.324</td></tr><tr><td align="left">Patients not receiving IS/CTC</td><td align="center">0.436</td></tr><tr><td align="left">Patients receiving hydroxychloroquine</td><td align="center">0.473</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Correlation between TST and T.SPOT.TB tests.

BioMed Research International

tab3

Table 3

Table 3: Diagnosis of Latent Tuberculosis in Patients with Systemic Lupus Erythematosus: T.SPOT.TB <i>versus</i> Tuberculin Skin Test 

BioMed Research International

Diagnosis of Latent Tuberculosis in Patients with Systemic Lupus Erythematosus: T.SPOT.TB versus Tuberculin Skin Test

Table 3